Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraovarian PRP for POI and POR
NCT04237909Completed
- Sponsor
- Acıbadem University
- Start
- Jan 2020
- Primary completion
- Oct 2020
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous platelet-rich plasma in premature ovarian insufficiency (POI) and poor ovarian response (POR), sponsored by Acıbadem University. Primary endpoint: Ovarian reserve parameters (AFC, FSH, AMH) at 6 months. Started Jan 2020; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
premature ovarian insufficiency (POI)poor ovarian response (POR)
Beyond the preview
Go deeper on NCT04237909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237909.